Freespira Launches Revolutionary 5th Generation Device
Freespira has introduced its fifth-generation device, renowned as Freespira Sensor Technology v5 (FST5). This innovative product reflects substantial enhancements in design, connectivity, and functionality, aimed at transforming the user experience for millions seeking relief from anxiety disorders.
Improving Treatment for Anxiety Disorders
This advanced medical device focuses on treating anxiety disorders such as panic disorder and post-traumatic stress disorder (PTSD). For the first time, the sensor and display are seamlessly integrated into one accessible unit, allowing for a more intuitive user experience.
Enhanced User Experience
The new integrated design not only simplifies the setup process but also minimizes the number of accessories required for operation. This effort exemplifies Freespira's dedication to maintaining high standards of reliability while enhancing the overall patient experience.
Features of the FST5
The FST5 is reported to integrate cutting-edge technology, including a hospital-grade non-dispersive infrared (NDIR) CO? measurement module. This component allows for accurate, real-time monitoring of respiration and end-tidal CO? levels, providing vital feedback to patients and health professionals.
Moreover, the FST5 eliminates the need for cumbersome weekly calibrations, promoting ease of use for patients and healthcare providers alike. It also boasts standardized Wi-Fi connectivity options, as well as cellular data capabilities that ensure reliable function both in clinical settings and at home.
Connecting Patients with Their Treatment
The efficacy of the FST5 lies in its ability to engage patients actively in their therapeutic process. Joe Perekupka, Freespira's CEO, emphasizes the importance of this device in reaching underrepresented communities that often face challenges with internet accessibility. This focus on connectivity aims to bridge gaps in care for those affected by anxiety disorders.
Commitment to Innovation and Accessibility
By integrating the sensor and display while expanding connectivity options, Freespira has made strides in ensuring that patients can interact comfortably and effectively with their treatment. Simon Thomas, President of Freespira, commented, "We want to make it easier than ever for patients to engage with our treatment without sacrificing the clinical precision that providers expect."
The introduction of a single charger and integrated cable further showcases the company's commitment to enhancing the daily experience for users, making interactions with the device as streamlined as possible.
Freespira's Legacy and Future
The innovative FST5 builds upon a decade of development and improvements seen since the release of its first edition in 2014. As the company continues to push the boundaries of treatment for panic attacks and PTSD symptoms, FST5 sets a new benchmark for capnography-guided respiratory intervention.
About Freespira, Inc.
Freespira, Inc. is dedicated to revolutionizing how anxiety disorders are treated through its groundbreaking technology. Their FDA-cleared digital therapeutic treatment has shown effectiveness in significantly alleviating symptoms within as little as 28 days. Various organizations, including health plans and the Veterans Administration, are already leveraging Freespira's medication-free solutions to enhance patients' quality of life and reduce healthcare costs.
Frequently Asked Questions
What is the Freespira Sensor Technology v5 (FST5)?
The FST5 is the latest medical device from Freespira that combines the sensor and display into a single unit, designed to treat anxiety disorders such as panic disorder and PTSD.
How does the FST5 improve patient experience?
Its integrated design simplifies setup and usage, while enhanced connectivity options allow for greater accessibility, particularly in underserved communities.
What technology does the FST5 use for monitoring?
The device utilizes a hospital-grade non-dispersive infrared (NDIR) CO? measurement module for accurate real-time monitoring of respiration and CO? levels.
What makes FST5 stand out from earlier models?
FST5 unifies previously separate components, eliminating the need for weekly calibration and enhancing overall usability, making it a significant advancement over prior models.
How can Freespira's solutions benefit healthcare systems?
By providing medication-free treatments, Freespira helps improve quality of life for patients while reducing overall healthcare costs, which can be beneficial for health plans and systems.
